Stay updated with breaking news from Daniel Karlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New research shows that a form of LSD may be an effective treatment for generalized anxiety disorder, with the FDA designating the drug as a breakthrough therapy.
A phase 2 clinical trial showed that MM-120 — a hallucinogen better known as LSD — could be effective in treating generalized anxiety disorder.
A lead candidate psychedelic drug developed by the US company MindMed has shown the potential to treat generalized anxiety disorder in a phase 2b trial.
A phase 2b clinical trial met its primary endpoint with positive topline results, showing MM-120 (lysergide d-tartrate) can reduce symptoms of generalized anxiety disorder, reflected in the Hamilton Anxiety rating scale scores.
Valley Drive has been under construction this summer—viewer Jennifer Vieth wanted to know what was going on with the project and if it would be done in time for the first day of school.